RecruitingSymptoms of Anxiety
Transcranial Photobiomodulation in Anxiety Disorders
Eligible age
18–100 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The investigators have previously shown that safe, non-invasive methods of brain stimulation such as the administration of transcranial infrared light can result in improvements to cognition and emotion. The investigators hypothesize that transcranial photobiomodulation (tPBM) can be used in conjunction with attention bias assessment and modification to reduce anxiety symptoms in individuals with sub-clinical anxiety.
Sponsor: Francisco Gonzalez-Lima, PhD
You may qualify if…
- ✓ 18 years of age and older
- ✓ State-Trait Anxiety Index (STAI) questionnaire score between 40-59 (indicates moderate sub-clinical anxiety)
- ✓ Patient Health Questionnaire (PHQ-9) score between 1-9 (indicates minimal to mild sub-clinical depression)
You may not qualify if…
- ✕ STAI score less than 40 or greater than 59
- ✕ PHQ-9 score greater than 9
- ✕ Medication instability (i.e., medication change within 6 weeks)
- ✕ Indicated suicidal ideation
- ✕ Currently receiving tPBM treatment
- ✕ Current pregnancy
Where it's recruiting
Texas
Austin
Source: ClinicalTrials.gov · NCT07133893 · last updated 2026-05-14